Survival Benefit, Toxic Profile, Cost Effectiveness in Patients Treated with 5 Fluoropyrimidine and Capecitabine for Colorectal Cancer in Adjuvant Setting

dc.contributor.author	Priyadarshani, H.H.C. (D 3932)
dc.date.accessioned	2025-06-20T07:32:36Z
dc.date.available	2025-06-20T07:32:36Z
dc.date.issued	2010
dc.identifier.uri	http://librepository.pgim.cmb.ac.lk/handle/1/6748
dc.language.iso	en	en_US
dc.publisher	Postgraduate Institute of Medicine	en_US
dc.subject	Survival Benefit	en_US
dc.subject	Toxic Profile	en_US
dc.subject	Cost Effectiveness	en_US
dc.subject	Patients Treated	en_US
dc.subject	5 Fluoropyrimidine	en_US
dc.subject	Capecitabine	en_US
dc.subject	Colorectal Cancer	en_US
dc.title	Survival Benefit, Toxic Profile, Cost Effectiveness in Patients Treated with 5 Fluoropyrimidine and Capecitabine for Colorectal Cancer in Adjuvant Setting	en_US
dc.type	Thesis	en_US